Loading…

Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress

African American men (AAM) are under-represented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low specificity for high-grade PCa leading to PCa over diagnosis. The Prostate Health Index (PHI) has higher specificity for lethal PCa but...

Full description

Saved in:
Bibliographic Details
Published in:Progress in community health partnerships 2019, Vol.13 (5), p.103-112
Main Authors: Watson, Karriem S, Henderson, Vida, Murray, Marcus, Murphy, Adam B, Levi, Josef Ben, McDowell, Tiffany, Holloway-Beth, Alfreda, Gogana, Pooja, Dixon, Michael A, Moore, LeAndre, Hall, Ivanhoe, Kimbrough, Alexander, Molina, Yamilé, Winn, Robert A
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:African American men (AAM) are under-represented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low specificity for high-grade PCa leading to PCa over diagnosis. The Prostate Health Index (PHI) has higher specificity for lethal PCa but needs validation in AAM. Engaging AAM as citizen scientists (CSs) may improve participation of AAM in PCa research.Results and Lessons Learned: Eight CSs completed all training modules and 139 AAM were recruited. Challenges included equity in research leadership among multiple principal investigators (PIs) and coordinating CSs trainings. Engaging AAM CSs can support engaging/recruiting AAM in PCa biomarker validation research. Equity among multiple stakeholders can be challenging, but proves beneficial in engaging AAM in research. Assess feasibility of mobilizing CSs to recruit AAM as controls for PHI PCa validation biomarker study. We highlight social networks/assets of stakeholders, CSs curriculum development/implementation, and recruitment of healthy controls for PHI validation.
ISSN:1557-0541
1557-055X
1557-055X
DOI:10.1353/cpr.2019.0043